What is the clinical indication for use of antileukotriene drug therapy,such as montelukast,in asthma?

Question

Quizplus · Accepted Answer

The following points summarize the current understanding of the role of antileukotriene drug therapy in asthma: •Antileukotriene agents are prophylactic,controller drugs used in persistent asthma,including mild,moderate,and severe states;they are not indicated for acute relief or rescue therapy. •Antileukotrienes can be tried as an alternative to inhaled corticosteroids or cromolynlike agents in mild persistent asthma requiring more than as-needed F1F1F1S1F1F1F10₂ agonists. •Antileukotrienes may not be optimal as monotherapy in persistent asthma. •Antileukotrienes may allow reduction of high-dose inhaled corticosteroids or prevent an increase in the dose of inhaled corticosteroids,and they reduce or prevent the need for oral corticosteroids. •Evidence to date shows these agents as safe and often effective choices in managing a wide range of asthma severity.

What Is the Clinical Indication for Use of Antileukotriene Drug